Skip to menu Skip to content Skip to footer

Phase 2 clinical study for a next-generation, needle free COVID-19 vaccine CRC-P administered by Vaxxas Pty Ltd) (2023-2025)

Experts

Associate Professor David Muller

Principal Research Fellow
School of Chemistry and Molecular Biosciences
Faculty of Science
David Muller
David Muller

Professor Paul Young

Professor, Research Development
Office of the Deputy Vice-Chancellor (Research and Innovation)
Paul Young
Paul Young